Certified Advisory Corp’s GenMark Diagnostics, Inc GNMK Stock Holding History

Certified Advisory Corp’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-340	Closed	-$2K	–	854
2019 Q4	$2K	Hold	340	–	–	﹤0.01%	753
2019 Q3	$2K	Hold	340	–	–	﹤0.01%	756
2019 Q2	$2K	Hold	340	–	–	﹤0.01%	763
2019 Q1	$2K	Hold	340	–	–	﹤0.01%	705
2018 Q4	$2K	Hold	340	–	–	﹤0.01%	700
2018 Q3	$2K	Hold	340	–	–	﹤0.01%	730
2018 Q2	$2K	Hold	340	–	–	﹤0.01%	719
2018 Q1	$1K	Hold	340	–	–	﹤0.01%	721
2017 Q4	$1K	Buy	+340	New	+$2.05K	﹤0.01%	682

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Certified Advisory Corp's GNMK Position: Q1 2020 in Review

Certified Advisory Corp sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2020, closing a stake of 340 shares — an estimated $2K sold.

Certified Advisory Corp first reported a position in GNMK in Q4 2017 and held it in 9 quarters. The position peaked at $2K in Q4 2019. 110 funds tracked by Wall St. Rank hold GNMK as of Q1 2020.

Certified Advisory Corp reported no remaining GenMark Diagnostics, Inc position as of Q1 2020 after selling out during the quarter.
Certified Advisory Corp sold 340 GenMark Diagnostics, Inc shares in Q1 2020, an estimated $2K.
Certified Advisory Corp first reported a position in GenMark Diagnostics, Inc in Q4 2017 and held it in 9 quarters.
Certified Advisory Corp's GenMark Diagnostics, Inc position peaked at $2K in Q4 2019.
110 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2020.

Based on Certified Advisory Corp's 13F filing for Q1 2020, filed 27 Apr 2020.